scholarly journals PDB44 EXAMINING THE RELATIONSHIP BETWEEN GLYCEMIC CONTROL AND MEDICATION ADHERENCE IN DIABETIC PATIENTS

2009 ◽  
Vol 12 (7) ◽  
pp. A409-A410
Author(s):  
SL Pinto ◽  
S Holl
Keyword(s):  
Medication Adherence ◽  
Glycemic Control ◽  
Diabetic Patients ◽  
The Relationship

scholarly journals The relationship between high-density lipoprotein cholesterol (HDL-C) and glycosylated hemoglobin in diabetic patients aged 20 or above: a cross-sectional study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Rui Huang ◽  
Li Yan ◽  
Yuhua Lei
Keyword(s):  
Glycemic Control ◽  
Interaction Analysis ◽  
Glycosylated Hemoglobin ◽  
Density Lipoprotein ◽  
Cross Sectional Study ◽  
Cerebrovascular Diseases ◽  
Diabetic Patients ◽  
Cross Sectional ◽  
Race Ethnicity ◽  
The Relationship

Abstract Aim The incidence rate of diabetes is increasing year by year, seriously threatening human health. As a predictor of glycemic control, glycated hemoglobin is reported to be related to various complications and prognoses of diabetes. Besides, HDL-C dyslipidemia is a component of metabolic syndrome and may be related to various cardiovascular and cerebrovascular diseases. The principal objective of this project was to investigate the relationship between HDL-C and glycosylated hemoglobin in adult diabetic patients. Methods A total of 3171 adult diabetic patients aged 20 years and above were included in the present study from the National Health and Nutrition Examination Survey (NHANES). HDL-C and glycosylated hemoglobin were regarded as independent and dependent variables, respectively. EmpowerStats software and R (version 3.4.3) were used to examine the association between HDL-C and glycosylated hemoglobin. Results HDL-C was inversely associated with glycohemoglobin after adjusting for other covariates (β = − 0.004, 95% CI:− 0.008 to − 0.000, p = 0.044). Race/ethnicity and age were considered the most prominent interactive factors that affect the relationship between HDL and glycosylated hemoglobin by the interaction analysis. A U-shaped association was detected between HDL-C and glycosylated hemoglobin for people of other race/ethnicity or aged 60 and above, which had an inflection point of HDL-C at 60 mg/dL. In contrast, we observed an inverted U-shaped distribution between HDL-C and glycosylated hemoglobin in people under 40 with point of inflection located at 60 mg/dL as well. Conclusions HDL-C in diabetic patients is inversely associated with glycosylated hemoglobin and may be relevant to glycemic control. However, a U-shaped relationship was also observed in a certain kind of people, which implied that, though HDL-C is considered as metabolism and anti-atherogenic property, for diabetics, it is not the higher, the better.

scholarly journals The Relationship of Illness Perception and Medication Adherence in Patients With Diabetes Mellitus Type II

2021 ◽  
Author(s):  
Sina Sabeti Bilondi ◽  
Ali Delshad Noghabi ◽  
Hosein Aalami
Keyword(s):  
Medication Adherence ◽  
Type Ii Diabetes ◽  
Pearson Correlation ◽  
Illness Perception ◽  
Personal Control ◽  
Diabetic Patients ◽  
Type Ii ◽  
Diabetes Clinic ◽  
The Mean ◽  
The Relationship

Abstract Background: One of the most well-known chronic diseases in the world is diabetes. Disease perception is the patient's organized cognitive representation of his or her illness and can affect treatment adherence. The aim of this study was to investigate the relationship between illness perception and adherence to the medical regimen in patients with type II diabetes. Methods: This descriptive-analytical cross-sectional study was performed on 260 patients with type II diabetes referred to Gonabad Diabetes Clinic by systematic random sampling in 2019. Data collection tools were demographic questionnaire, Morisky medication Adherence Scale (MMAS-8), and Brief illness Perception Questionnaire (BIPQ). Data were analyzed by SPSS 20 software. And using descriptive statistics, Pearson correlation coefficient. P < 0.05 was considered significant. Results: The results showed that the mean score of illness perception of type II diabetes was 46.39 ± 9.45 (range 0-70) and the mean score of medication Adherence was 2.93 ± 1.9 (range 0-8). The results of Pearson correlation test showed a significant relationship between illness perception and medication Adherence (P <0.001, r = 0.199). Also, the regression model showed that the dimensions of disease comprehension and personal control from illness perception were significantly related to medication Adherence of type II diabetic patients (P <0.001). Conclusion: By measuring the level of illness perception, the degree of medication Adherence can be predicted. Therefore, strengthening the illness perception in order to medication Adherence seems to be an important therapeutic strategy in educational interventions. Keywords: illness perception, medication Adherence, type II diabetes

scholarly journals The relationship between glycemic control and BNP levels in diabetic patients

2013 ◽  
Author(s):  
Kursad Dal ◽  
Naim Ata ◽  
Bunyamin Yavuz ◽  
Omer Sen ◽  
Guler Kizilca ◽  
...  
Keyword(s):  
Glycemic Control ◽  
Diabetic Patients ◽  
The Relationship

Impact of cancer related stress on illness beliefs and glycemic control in breast cancer survivors with comorbid diabetes.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e24053-e24053
Author(s):  
Jenny J. Lin ◽  
Janey James ◽  
Mita Goel ◽  
Yael T Harris
Keyword(s):  
Breast Cancer ◽  
Medication Adherence ◽  
Glycemic Control ◽  
Cancer Survivors ◽  
Breast Cancer Survivors ◽  
Illness Beliefs ◽  
Event Scale ◽  
Related Stress ◽  
The Impact ◽  
The Relationship

e24053 Background: Cancer and diabetes mellitus (DM) are leading causes of death in the US and survivors with comorbid DM have a significantly higher mortality. Furthermore, posttraumatic stress disorder (PTSD) can be triggered by life-threatening illnesses such as cancer; however, little is known about the impact of cancer-related PTSD (Ca-PTSD) on illness beliefs and glycemic control. We undertook this study to assess factors associated with DM management in breast cancer survivors with DM. Methods: We recruited women with Stage 0-IIIA breast cancer diagnosed in the past 10 years, who had completed chemotherapy and/or hormonal therapy and had pre-existing DM on ≥1 oral DM medication. The Impact of Event Scale-Revised (IES-R) was used to assess distress caused by cancer. A total IES-R score of ≥33 identified those with probable Ca-PTSD. Cancer and DM related beliefs were assessed using the Illness Perception Questionnaire. Objective adherence to DM medication was assessed using electronic caps that record bottle openings. Wilcoxon rank-sum tests were used to examine the relationship between Ca-PTSD and illness beliefs. Pearson correlation tests were used to assess the relationship between cancer related stress, DM medication adherence, and glycemic control. Results: Of 111 women recruited to date, mean age was 65.4 years and 37% were black, 31% white, 14% Hispanic, 6% Asian, and 8% other. Of these, 15% had probable Ca-PTSD. Survivors with Ca-PTSD were more likely to believe the consequences of cancer and DM were more severe (median score 23.5 vs. 19.0 [p < 0.001] and 24.0 vs. 16.0 [p < 0.001], respectively), that cancer and DM were more cyclical or recurrent (15.0 vs. 9.0 [p = 0.002] and 13.0 vs. 8.5 [p = 0.002], respectively), and there was greater emotional impact due to cancer and DM (24.0 vs. 16.5 [p < 0.001] and 23.0 vs. 14.0 [p < 0.001], respectively). Additionally, those with Ca-PTSD were less likely to understand their cancer (14.0 vs. 20.0, p = 0.004). Furthermore, as cancer-related stress scores increased, glycemic control worsened (r = 0.23, p = 0.03) and DM medication adherence decreased (r = -0.23, p = 0.04). Conclusions: Breast cancer survivors with comorbid DM who have Ca-PTSD are more likely to have negative beliefs about both cancer and DM. Cancer-related stress is also associated with poorer glycemic control and DM medication adherence. Providers should be aware of the impact of cancer related stress on beliefs about comorbid illnesses and increase interventions that support cancer survivors to better manage their comorbidities.

Comparison of Glycated Albumin and Hemoglobin A1cConcentrations in Diabetic Subjects on Peritoneal and Hemodialysis

2010 ◽  
Vol 30 (1) ◽  
pp. 72-79 ◽  
Author(s):  
Barry I. Freedman ◽  
Rajeev N. Shenoy ◽  
Jonathan A. Planer ◽  
Kimberly D. Clay ◽  
Zak K. Shihabi ◽  
...  
Keyword(s):  
Glycemic Control ◽  
Glycated Albumin ◽  
Serum Glucose ◽  
Outcome Variable ◽  
Diabetic Patients ◽  
Dialysis Patients ◽  
Glucose Levels ◽  
Stage Renal Disease ◽  
End Stage ◽  
The Relationship

BackgroundRelative to hemoglobin A1c(HbA1c), percentage of glycated albumin (GA%) more accurately reflects recent glycemic control in diabetic hemodialysis (HD) patients.MethodsTo determine the accuracy of glycemic assays in a larger sample including patients on peritoneal dialysis (PD), HbA1cand GA% were measured in 519 diabetic subjects: 55 on PD, 415 on HD, and 49 non-nephropathy controls.ResultsMean ± SD serum glucose levels were higher in HD and PD patients relative to non-nephropathy controls (HD 169.7 ± 62 mg/dL, PD 168.6 ± 66 mg/dL, controls 146.1 ± 66 mg/dL; p = 0.03 HD vs controls, p = 0.13 PD vs controls). GA% was also higher in HD and PD patients (HD 20.6% ± 8.0%, PD 19.0% ± 5.7%, controls 15.7% ± 7.7%; p < 0.02 HD vs controls and PD vs controls). HbA1cwas paradoxically lower in dialysis patients (HD 6.78% ± 1.6%, PD 6.87% ± 1.4%, controls 7.3% ± 1.4%; p = 0.03 HD vs controls, p = 0.12 PD vs controls). The serum glucose/HbA1cratio differed significantly between dialysis patients and controls ( p < 0.0001 HD vs controls, p = 0.002 PD vs controls), while serum glucose/GA% ratio was similar across groups ( p = 0.96 HD vs controls, p = 0.64 PD vs controls). In best-fit multivariate models with HbA1cor GA% as outcome variable, dialysis status was a significant predictor of HbA1cbut not GA%.ConclusionsThe relationship between HbA1cand GA% differs in diabetic patients with end-stage renal disease who perform either PD or HD compared to those without nephropathy. HbA1csignificantly underestimates glycemic control in peritoneal and hemodialysis patients relative to GA%.

Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature

2002 ◽  
Vol 32 (3) ◽  
pp. 235-247 ◽  
Author(s):  
Ryan J. Anderson ◽  
Allison B. Grigsby ◽  
Kenneth E. Freedland ◽  
Mary De Groot ◽  
Janet B. McGill ◽  
...  
Keyword(s):  
Glycemic Control ◽  
Meta Analysis ◽  
Poor Glycemic Control ◽  
Diabetic Patients ◽  
Collective Data ◽  
Diagnostic Interviews ◽  
Analytic Review ◽  
The Relationship

Objective: To determine whether anxiety is associated with poor glycemic control in adults with type 1 or type 2 diabetes. Method: MEDLINE, PubMed, and PsycINFO databases were used to locate studies that measured the association of anxiety with glycemic control. Meta-analytic procedures were used to convert the findings to a common metric, compute effect sizes (ES), and statistically analyze the collective data. Results: The search procedures identified 12 studies, 11 (92 percent) of which satisfied the criteria for inclusion in the meta-analysis. In this overall group, anxiety was not associated with glycemic control ( p = 0.19), although the ES was marginally statistically significant (ES = .09, 95 percent CI = 0.04 to 0.14). In studies that determined anxiety from diagnostic interviews, anxiety was associated with hyperglycemia ( p = 0.003) and the ES was also statistically significant (ES: 0.25, 95 percent CI = 0.10 to 0.38). Conclusions: The existing literature suggests that anxiety disorders are associated with hyperglycemia in diabetic patients. Additional studies are required to confirm the magnitude of the relationship, to elucidate moderating and causal factors, and to determine whether successful treatment of anxiety improves glycemic control.

Sign in / Sign up

Export Citation Format

Share Document